➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
Johnson and Johnson
Express Scripts
Harvard Business School
Medtronic

Last Updated: December 3, 2020

DrugPatentWatch Database Preview

Litigation Details for Pfizer Inc. v. Teva Pharmaceuticals USA, Inc. (E.D. Va. 2010)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Pfizer Inc. v. Teva Pharmaceuticals USA, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Pfizer Inc. v. Teva Pharmaceuticals USA, Inc. (E.D. Va. 2010)

Date Filed Document No. Description Snippet Link To Document
2011-03-17 113 the alleged infringement of United States Patent No. 6,469,012 (filed May 13, 1994) (issued…. This patent is different than the '012 patent because the 4012 patent is a method patent for a number… had been previously patented, the '012 patent was unique because it patented sildenafil, along with… v012 patent are invalid and Teva's planned drug will not infringe any patentable claim…Pfizer also holds another patent specifically for sildenafil in United States Patent No. 5,250,534, which External link to document
2010-04-29 19 012 Patent 13. Teva USA admits that according to the face of U.S. Patent No. 6,469,012 (“the…“the ‘012 patent”), the ‘012 patent is titled “Pyrazolopyrimidinones for the Treatment of Impotence,”…that according to the face of the ‘012 patent, the ‘012 patent issued to Pfizer, Inc. as the assignee …the United States Patent and Trademark Office (“PTO”) has reexamined the ‘012 patent, and that claims …matter described in claim 24 of the ‘012 patent is not patentable. Teva USA further admits that what appears External link to document
2011-07-05 411 21:7 (‘534 patent); SUF ¶ 17), and (2) U.S. Patent No. 6,469,012 (“the ‘012 patent”), which claims…earlier-issued patent – the ‘534 patent. Thus, it is the ‘534 patent, not the ‘012 patent, that has a …26 OF THE ‘012 PATENT ARE NOT PATENTABLY DISTINCT FROM CLAIM 1 OF THE ‘270 PATENT..............…lists two patents in connection with VIAGRA®: (1) U.S. Patent No. 5,250,534 (“the ‘534 patent”), which… of the ‘012 patent. SUF ¶ 10. C. The Patent-In-Suit: The ‘012 Patent 17 External link to document
2011-08-12 470 #39;s United States Patent No. 6,469,012 ("the '012 patent"), entitled… United States Patent No. 6,469,012 (filed May 13, 1994) … Patent Number 6,100,270 {"the *270 patent"). United States Patent No. …#39;012 patent, PTX 0001, with '270 patent, DX 2066. Thus, the '270 patent is considered…the '012 patent was invalid for double patenting based on both the '270 patent and United States External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Medtronic
McKinsey
Moodys
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.